Upgrade to SI Premium - Free Trial

Strategy (MSTR) PT Raised to $40,000 at TD Cowen on 'Stronger Execution'

May 19, 2026 7:44 AM
(Updated - May 19, 2026 10:12 AM EDT)

TD Cowen analyst Lance Vitanza raised the price target on Strategy (NASDAQ: MSTR) to $40,000.00 (from $395.00) while maintaining a Buy rating.

The analyst commented: "Accelerating BTC/Share and Accretive Deleveraging Support PT to $400; Strategy’s treasury operations continue to exceed expectations, with faster-than-anticipated bitcoin accumulation and accretive balance sheet actions driving higher BTC per share and improved financial flexibility. We raise our FY26 BTC Yield and BTC $ Gain estimates and increase our price target to $400 (from $395), reflecting stronger execution and sustained access to capital markets."

Categories

Analyst Comments Analyst PT Change